Skip to main content
Top
Published in: Digestive Diseases and Sciences 12/2020

01-12-2020 | Helicobacter Pylori | Original Article

Exosomal hsa-miR-933 in Gastric Juice as a Potential Biomarker for Functional Dyspepsia

Authors: Fumio Tanaka, Shingo Takashima, Yuji Nadatani, Koji Otani, Shuhei Hosomi, Noriko Kamata, Koichi Taira, Yasuaki Nagami, Tetsuya Tanigawa, Shinya Fukumoto, Toshio Watanabe, Yoshiki Murakami, Norifumi Kawada, Yasuhiro Fujiwara

Published in: Digestive Diseases and Sciences | Issue 12/2020

Login to get access

Abstract

Background

MicroRNAs (miRNAs) in exosomes represent disease-specific profiles and are applied as biomarkers in oncology. However, in functional dyspepsia (FD), the role of exosomal miRNAs has not been fully elucidated.

Aims

To investigate exosomal miRNAs as potential biomarkers of FD using liquid biopsy.

Methods

This retrospective cohort study included 11 subjects with FD and 11 age- and sex-matched healthy controls (HCs). We collected gastric juice and isolated exosomal miRNAs. In a discovery cohort, expression levels of 2565 miRNAs were evaluated by 3D-Gene® microarray. miRNA expression profiles from exosomes of subjects with FD and HCs were compared by two normalization methods: (1) global normalization and (2) normalization by internal control. Subsequently, in a validation cohort, the expression levels of miRNAs were validated by quantitative reverse transcription PCR (RT-qPCR).

Results

Through microarray analysis using the two methods, we identified 39 miRNAs that were consistently and significantly downregulated in FD cases compared with those in HCs. Of these, 12 miRNAs (hsa-miR-933, hsa-miR-345-5p, hsa-miR-708-5p, hsa-miR-203a-3p, hsa-miR-619-5p, hsa-miR-4294, hsa-miR-4481, hsa-miR-196a-5p, hsa-miR-3918, hsa-miR-372-3p, hsa-miR-658, and hsa-miR-3654) were further validated by RT-qPCR. Our results indicated that hsa-miR-933 was significantly downregulated in FD compared with HCs (0.317 ± 0.205-fold, P = 0.0317). Furthermore, the expression level of hsa-miR-933 was negatively associated with dyspepsia score and the frequency of epigastric pain and/or burning (P < 0.01, r = − 0.835; P = 0.0280, r = − 0.688, respectively).

Conclusions

Exosomal hsa-miR-933 in gastric juice could be a candidate biomarker for FD.
Literature
1.
go back to reference Stanghellini V, Chan FK, Hasler WL, et al. Gastroduodenal disorders. Gastroenterology. 2016;150:1380–1392.CrossRef Stanghellini V, Chan FK, Hasler WL, et al. Gastroduodenal disorders. Gastroenterology. 2016;150:1380–1392.CrossRef
2.
go back to reference Miwa H, Oshima T, Tomita T, et al. Recent understanding of the pathophysiology of functional dyspepsia: role of the duodenum as the pathogenic center. J Gastroenterol. 2019;54:305–311.CrossRef Miwa H, Oshima T, Tomita T, et al. Recent understanding of the pathophysiology of functional dyspepsia: role of the duodenum as the pathogenic center. J Gastroenterol. 2019;54:305–311.CrossRef
4.
go back to reference Tominaga K, Higuchi K, Iketani T, et al. Comparison of gastrointestinal symptoms and psychological factors of functional dyspepsia to peptic ulcer or panic disorder patients. Inflammopharmacology. 2007;15:84–89.CrossRef Tominaga K, Higuchi K, Iketani T, et al. Comparison of gastrointestinal symptoms and psychological factors of functional dyspepsia to peptic ulcer or panic disorder patients. Inflammopharmacology. 2007;15:84–89.CrossRef
5.
go back to reference Moayyedi P, Lacy BE, Andrews CN, et al. ACG and CAG clinical guideline: management of dyspepsia. Am J Gastroenterol. 2017;112:988–1013.CrossRef Moayyedi P, Lacy BE, Andrews CN, et al. ACG and CAG clinical guideline: management of dyspepsia. Am J Gastroenterol. 2017;112:988–1013.CrossRef
6.
go back to reference Miwa H, Kusano M, Arisawa T, et al. Evidence-based clinical practice guidelines for functional dyspepsia. J Gastroenterol. 2015;50:125–139.CrossRef Miwa H, Kusano M, Arisawa T, et al. Evidence-based clinical practice guidelines for functional dyspepsia. J Gastroenterol. 2015;50:125–139.CrossRef
7.
go back to reference Murakami Y, Toyoda H, Tanahashi T, et al. Comprehensive miRNA expression analysis in peripheral blood can diagnose liver disease. PLoS One. 2012;7:e48366.CrossRef Murakami Y, Toyoda H, Tanahashi T, et al. Comprehensive miRNA expression analysis in peripheral blood can diagnose liver disease. PLoS One. 2012;7:e48366.CrossRef
8.
go back to reference Kutwin P, Konecki T, Borkowska EM, Traczyk-Borszyńska M, Jabłonowski Z. Urine miRNA as a potential biomarker for bladder cancer detection - a meta-analysis. Cent Eur J Urol. 2018;71:177–185. Kutwin P, Konecki T, Borkowska EM, Traczyk-Borszyńska M, Jabłonowski Z. Urine miRNA as a potential biomarker for bladder cancer detection - a meta-analysis. Cent Eur J Urol. 2018;71:177–185.
9.
go back to reference Arantes LMRB, De Carvalho AC, Melendez ME, Lopes Carvalho A. Serum, plasma and saliva biomarkers for head and neck cancer. Expert Rev Mol Diagn. 2018;18:85–112.CrossRef Arantes LMRB, De Carvalho AC, Melendez ME, Lopes Carvalho A. Serum, plasma and saliva biomarkers for head and neck cancer. Expert Rev Mol Diagn. 2018;18:85–112.CrossRef
10.
go back to reference Kagota S, Taniguchi K, Lee SW, et al. Analysis of extracellular vesicles in gastric juice from gastric cancer patients. Int J Mol Sci. 2019;20:953.CrossRef Kagota S, Taniguchi K, Lee SW, et al. Analysis of extracellular vesicles in gastric juice from gastric cancer patients. Int J Mol Sci. 2019;20:953.CrossRef
11.
go back to reference Lin J, Li J, Huang B, et al. Exosomes: novel biomarkers for clinical diagnosis. Sci World J. 2015;2015:657086. Lin J, Li J, Huang B, et al. Exosomes: novel biomarkers for clinical diagnosis. Sci World J. 2015;2015:657086.
12.
go back to reference Nedaeinia R, Manian M, Jazayeri MH, et al. Circulating exosomes and exosomal microRNAs as biomarkers in gastrointestinal cancer. Cancer Gene Ther. 2017;24:48–56.CrossRef Nedaeinia R, Manian M, Jazayeri MH, et al. Circulating exosomes and exosomal microRNAs as biomarkers in gastrointestinal cancer. Cancer Gene Ther. 2017;24:48–56.CrossRef
13.
go back to reference Gregory RI, Yan KP, Amuthan G, et al. The microprocessor complex mediates the genesis of microRNAs. Nature. 2004;432:235–240.CrossRef Gregory RI, Yan KP, Amuthan G, et al. The microprocessor complex mediates the genesis of microRNAs. Nature. 2004;432:235–240.CrossRef
14.
go back to reference Huang Z, Huang D, Ni S, et al. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer. 2010;127:118–126.CrossRef Huang Z, Huang D, Ni S, et al. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer. 2010;127:118–126.CrossRef
15.
go back to reference Zhow W, Fong MY, Min Y, et al. Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis. Cancer Cell. 2014;25:501–515.CrossRef Zhow W, Fong MY, Min Y, et al. Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis. Cancer Cell. 2014;25:501–515.CrossRef
16.
go back to reference Chen WX, Liu XM, Lv MM, et al. Exosomes from drug-resistant breast cancer cells transmit chemoresistance by a horizontal transfer of microRNAs. PLoS One. 2014;9:e95240.CrossRef Chen WX, Liu XM, Lv MM, et al. Exosomes from drug-resistant breast cancer cells transmit chemoresistance by a horizontal transfer of microRNAs. PLoS One. 2014;9:e95240.CrossRef
17.
go back to reference Deng Y, Zhou X, Xiang X, Ou Y, He J. Effect of miRNA-19a on gastrointestinal motility in rats with functional dyspepsia. Exp Ther Med. 2018;15:4875–4879.PubMedPubMedCentral Deng Y, Zhou X, Xiang X, Ou Y, He J. Effect of miRNA-19a on gastrointestinal motility in rats with functional dyspepsia. Exp Ther Med. 2018;15:4875–4879.PubMedPubMedCentral
18.
go back to reference Arisawa T, Tahara T, Fukuyama T, et al. Genetic polymorphism of pri-microRNA 325, targeting SLC6A4 3′-UTR, is closely associated with the risk of functional dyspepsia in Japan. J Gastroenterol. 2012;47:1091–1098.CrossRef Arisawa T, Tahara T, Fukuyama T, et al. Genetic polymorphism of pri-microRNA 325, targeting SLC6A4 3′-UTR, is closely associated with the risk of functional dyspepsia in Japan. J Gastroenterol. 2012;47:1091–1098.CrossRef
19.
go back to reference Kanazawa M, Nakajima S, Oshima T, et al. Validity and reliability of the Japanese version of the Rome III diagnostic questionnaire for irritable bowel syndrome and functional dyspepsia. J Neurogastroenterol Motil. 2015;21:537–544.CrossRef Kanazawa M, Nakajima S, Oshima T, et al. Validity and reliability of the Japanese version of the Rome III diagnostic questionnaire for irritable bowel syndrome and functional dyspepsia. J Neurogastroenterol Motil. 2015;21:537–544.CrossRef
20.
go back to reference Kusano M, Hosaka H, Kawada A, et al. Development and evaluation of a modified frequency scale for the symptoms of gastroesophageal reflux disease to distinguish functional dyspepsia from non-erosive reflux disease. J Gastroenterol Hepatol. 2012;27:1187–1191.CrossRef Kusano M, Hosaka H, Kawada A, et al. Development and evaluation of a modified frequency scale for the symptoms of gastroesophageal reflux disease to distinguish functional dyspepsia from non-erosive reflux disease. J Gastroenterol Hepatol. 2012;27:1187–1191.CrossRef
21.
go back to reference Tanaka F, Tominaga K, Fujikawa Y, et al. Association between functional dyspepsia and gastric depressive erosions in japanese subjects. Intern Med. 2019;58:321–328.CrossRef Tanaka F, Tominaga K, Fujikawa Y, et al. Association between functional dyspepsia and gastric depressive erosions in japanese subjects. Intern Med. 2019;58:321–328.CrossRef
22.
go back to reference Sudo K, Kato K, Matsuzaki J, et al. Development and validation of an esophageal squamous cell carcinoma detection model by large-scale MicroRNA profiling. JAMA Netw Open. 2019;2:e194573.CrossRef Sudo K, Kato K, Matsuzaki J, et al. Development and validation of an esophageal squamous cell carcinoma detection model by large-scale MicroRNA profiling. JAMA Netw Open. 2019;2:e194573.CrossRef
23.
go back to reference Asano N, Matsuzaki J, Ichikawa M, et al. A serum microRNA classifier for the diagnosis of sarcomas of various histological subtypes. Nat Commun. 2019;10:1299.CrossRef Asano N, Matsuzaki J, Ichikawa M, et al. A serum microRNA classifier for the diagnosis of sarcomas of various histological subtypes. Nat Commun. 2019;10:1299.CrossRef
24.
go back to reference Brazma A, Hingamp P, Quackenbush J, et al. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet. 2001;29:365–371.CrossRef Brazma A, Hingamp P, Quackenbush J, et al. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet. 2001;29:365–371.CrossRef
25.
go back to reference Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 2013;48:452–458.CrossRef Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 2013;48:452–458.CrossRef
26.
go back to reference Wong N, Wang X. miRDB: an online resource for microRNA target prediction and functional annotations. Nucleic Acids Res. 2015;43:D146–152.CrossRef Wong N, Wang X. miRDB: an online resource for microRNA target prediction and functional annotations. Nucleic Acids Res. 2015;43:D146–152.CrossRef
27.
go back to reference Liu W, Wang X. Prediction of functional microRNA targets by integrative modeling of microRNA binding and target expression data. Genome Biol. 2019;20:18.CrossRef Liu W, Wang X. Prediction of functional microRNA targets by integrative modeling of microRNA binding and target expression data. Genome Biol. 2019;20:18.CrossRef
28.
go back to reference Machaalani R, Chen H. Brain derived neurotrophic factor (BDNF), its tyrosine kinase receptor B (TrkB) and nicotine. Neurotoxicology. 2018;65:186–195.CrossRef Machaalani R, Chen H. Brain derived neurotrophic factor (BDNF), its tyrosine kinase receptor B (TrkB) and nicotine. Neurotoxicology. 2018;65:186–195.CrossRef
29.
go back to reference Lu B, Nagappan G, Guan X, Nathan PJ, Wren P. BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases. Nat Rev Neurosci. 2013;14:401–416.CrossRef Lu B, Nagappan G, Guan X, Nathan PJ, Wren P. BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases. Nat Rev Neurosci. 2013;14:401–416.CrossRef
30.
go back to reference Tronci E, Napolitano F, Muñoz A, et al. BDNF over-expression induces striatal serotonin fiber sprouting and increases the susceptibility to l-DOPA-induced dyskinesia in 6-OHDA-lesioned rats. Exp Neurol. 2017;297:73–81.CrossRef Tronci E, Napolitano F, Muñoz A, et al. BDNF over-expression induces striatal serotonin fiber sprouting and increases the susceptibility to l-DOPA-induced dyskinesia in 6-OHDA-lesioned rats. Exp Neurol. 2017;297:73–81.CrossRef
31.
go back to reference Castrén E, Kojima M. Brain-derived neurotrophic factor in mood disorders and antidepressant treatments. Neurobiol Dis. 2017;97:119–126.CrossRef Castrén E, Kojima M. Brain-derived neurotrophic factor in mood disorders and antidepressant treatments. Neurobiol Dis. 2017;97:119–126.CrossRef
32.
go back to reference Coulie B, Szarka LA, Camilleri M, et al. Recombinant human neurotrophic factors accelerate colonic transit and relieve constipation in humans. Gastroenterology. 2000;119:41–50.CrossRef Coulie B, Szarka LA, Camilleri M, et al. Recombinant human neurotrophic factors accelerate colonic transit and relieve constipation in humans. Gastroenterology. 2000;119:41–50.CrossRef
33.
go back to reference Wang P, Du C, Chen FX, et al. BDNF contributes to IBS-like colonic hypersensitivity via activating the enteroglia-nerve unit. Sci Rep. 2016;6:20320.CrossRef Wang P, Du C, Chen FX, et al. BDNF contributes to IBS-like colonic hypersensitivity via activating the enteroglia-nerve unit. Sci Rep. 2016;6:20320.CrossRef
Metadata
Title
Exosomal hsa-miR-933 in Gastric Juice as a Potential Biomarker for Functional Dyspepsia
Authors
Fumio Tanaka
Shingo Takashima
Yuji Nadatani
Koji Otani
Shuhei Hosomi
Noriko Kamata
Koichi Taira
Yasuaki Nagami
Tetsuya Tanigawa
Shinya Fukumoto
Toshio Watanabe
Yoshiki Murakami
Norifumi Kawada
Yasuhiro Fujiwara
Publication date
01-12-2020
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 12/2020
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-020-06096-7

Other articles of this Issue 12/2020

Digestive Diseases and Sciences 12/2020 Go to the issue